|
Throughout the centuries, much work has been done to seek out a cure for the nocturnal passions of the vampire. Various rituals, exorcisms, and laying-on of hands have all been tried... but in 'vein.' Of late, a bold manufacturer has been able to synthesize a hybrid molecule whose structure bestows it with potency against the affliction of vampirism. While its duration of action is limited, it is the first of what will hopefully be many steps toward a cure. Given its unique mode of action, this class of medicine has been dubbed thanatoxin by its creator.
It was France's illustrious Iksleikta Pharmaceuticals who first discovered the peculiar molecular formula. After many years of perfecting the steps necessary to make its mass production feasible, Iksleikta has allowed its marketing through an American firm, Credible Medicinals [underwritten by Blythe Labs and thus known as CMB]. CMB has provided for this website a drug information sheet in anticipation of the medicine's forthcoming release onto the market. So, for you vampires who have been seeking an 'out' for your woes and miseries, feast your eyes on this! 
|
CMB - Copyright © 1996-9